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Abstract.  Posttranslational processing of many pro- 
teins is essential to the synthesis of fully functional 
molecules. The ELH (egg-laying hormone) prohor- 
mone is cleaved by endoproteases in a  specific order 
at a variety of basic residue processing sites to pro- 
duce mature peptides.  The prohormone is first cleaved 
at a unique tetrabasic site liberating two intermediates 
(amino and carboxy) which are sorted to different 
classes of dense core vesicles in the bag cell neurons 
of Aplysia.  When expressed in AtT-20 cells, the ELH 
prohormone is also first cleaved at the tetrabasic site. 
The amino-terminal  intermediate is then sorted to the 
constitutive pathway,  and a portion of the carboxy- 
terminal  intermediate is sorted to the regulated path- 
way. Here, we use mutant constructs of the ELH pro- 
hormone expressed in AtT-20 cells to examine the 
relationship between prohormone processing and con- 
sequent sorting.  Prohormone which has a dibasic site 
in place of the tetrabasic site is processed and sorted 
similarly to wild type. Furthermore,  mutant prohor- 
mone which lacks the tetrabasic site is processed at an 
alternative site comprising three basic residues.  In 
these mutant prohormones,  mature ELH is still  pro- 
duced and stored in dense core vesicles while amino- 
terminal products are constitutively secreted.  However, 
deletion of the tetrabasic and tribasic sites results in 
the rerouting of the amino-terminal  intermediate prod- 
ucts from the constitutive pathway to the regulated 
secretory pathway.  Thus,  in the ELH prohormone,  the 
location of the proteolytic processing events within the 
secretory pathway and the order of cleavages regulate 
the sorting of peptide products. 
T  HF. maturation of a prohormone involves many highly 
regulated  cellular and biochemical steps in the secre- 
tory pathway. First, the signal sequence of the prohor- 
mone is cleaved in the ER (Walter et al., 1984). Then, during 
vectorial transport through the Golgi complex, further matu- 
ration including  glycosylation,  sulfation,  and phosphoryla- 
tion may occur (Huttner,  1988; Eipper and Mains,  1982). In 
the  late  Golgi  compartments,  possibly  the  trans-Golgi 
(TG) 1 or TGN,  proteolytic processing can occur, as is the 
case with the ELH prohormone of bag cell neurons (Sossin, 
et al.,  1990a),  viral proteins (e.g., McCune et al.,  1988), 
growth factors, and receptors (e.g., Yoshimasa et al., 1990). 
At the TGN, proteins are sorted to one of several destina- 
tions:  the plasma  membrane,  lysosomes, the constitutive 
pathway, or the regulated secretory pathway (Kelly,  1985; 
Grifliths  and  Simons,  1986).  Prohormone  products  are 
sorted to the regulated pathway and are stored in dense core 
vesicles (DCVs). It is during the maturation  of the DCVs that 
the  final  processing  steps,  such  as  cleavage  at  dibasic 
residues  (Orci  et  al.,  1987, 1988),  removal  of the  basic 
residues by a carboxypeptidase, and amidation  are thought 
1. Abbreviations  used in this paper: DCV, dense core vesicles; EGH, egg- 
laying hormone; KLH, keyhole limpet hemocyanin; PCE, prohormone con- 
verting enzymes; "l'G, trans-Golgi. 
to  occur  (for  reviews  see  Docherty  and  Steiner,  1982; 
Douglass and Herbert, 1984; Loh et al., 1984; Sossin et al., 
1990a). 
Basic residues, and especially the Lys-Arg dibasic pair, are 
common  proteolytic  recognition  sites.  However,  in  the 
course of prohormone maturation,  only some of the available 
basic residue sites are cleaved.  Hence, there must be infor- 
mation  in  the  sequence that  confers  cleavage  specificity 
(Rholam et al.,  1986).  Biophysical  studies  using  synthetic 
peptides corresponding to regions  surrounding  the process- 
ing site in prooxytocin have shown that  certain secondary 
structures  are important for cleavage. Specifically, a/3 turn 
subtype on the amino-terminal  side of the dibasic cleavage 
site and an a  helix on the carboxy-terminal  side are impor- 
tant structural  features for enzyme recognition  and utiliza- 
tion of the cleavage site (Paolillo  et al.,  1992). 
Several  enzymes involved  in  the processing of prohor- 
mones have been identified  and are referred  to as prohor- 
mone  converting  enzymes  (PCEs)  (for reviews  see Barr, 
1991;  Steiner,  1991). Furin,  the  first  mammalian  PCE 
identified due to its homology with the yeast proteolytic pro- 
hormone processing enzyme Kex2 (Fuller et al.,  1988), is 
ubiquitous in mammalian  cell types (Schalken et al.,  1987, 
Van de Ouweland et al.,  1990).  The proposed furin  con- 
sensus  sequence,  Arg-X-Arg/Lys-Arg (Hosaka et al.,  1991) 
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tors, and proreceptors than in prohormones. Other PCEs in- 
clude PC1/PC3 (Seidah et al., 1991; Smeekens et al., 1991) 
and PC2 (Seidah et al., 1990; Smeekens and Steiner, 1990). 
In cellular transfection studies, it was shown that cleavage by 
PC1/PC3 is specific for the dibasic site between ACTH and 
/~-lipotropin  of the proopiomelanocortin precursor,  while 
cleavage by PC2  is more specific for the internal dibasic 
cleavage in/~-lipotropin to produce/3-endorphin (Benjannet 
et al., 1991; Thomas et al., 1991). More PCEs are likely to 
be characterized, suggesting that particular enzymes may be 
required for specific cleavages.  Furin is thought to be local- 
ized in the Golgi complex, because it contains a transmem- 
brane domain; studies also suggest that a furin-like proteo- 
lyric activity is present in this compartment. The cellular 
locations of PC1/PC3 and PC2 have yet to be determined. 
Since they lack transmembrane domains, it is thought that 
they are in DCVs. The actual intracellular location and sites 
of action of these enzymes are of interest and importance in 
understanding the regulation of prohormone biosynthesis. 
The emphases of many studies have been on the identi- 
fication of structural components of the prohormones and 
molecular mechanisms involved in sorting proteins to the 
constitutive or regulated secretory pathways.  In this paper, 
we investigate the role of proteolytic processing in the sort- 
ing ofprohormone products. The egg-laying hormone (ELH) 
prohormone  encodes  several  biologically active  peptides 
that regulate the egg-laying behavior in the marine mollusc 
Aplysia californica. The order and cellular location of its 
processing have been studied intensively (Newcomb et al., 
1987; Fisher et al., 1988; Sossin et al., 1990a,b). After the 
signal sequence cleavage, a unique tetrabasic site is cleaved 
late in the Golgi apparatus. As a result, amino-terminal (F2) 
and carboxy-terminal (13) intermediates are liberated (see 
Fig. 1). These two intermediates are proposed to be differen- 
tially sorted in the TGN: amino-terminal intermediate pep- 
tides and the carboxy-terminal product, ELH, are packaged 
into different DCV classes. Furthermore, the cell modulates 
the relative levels of the peptides, possibly by shunting some 
of the amino-terminal intermediate to the lysosomal degra- 
dative pathway (Sossin et al., 1990a).  Hence, while the bag 
cell peptides and ELH are initially encoded in an equimolar 
ratio, the final ratio of recovered peptides is 1 to 5 amino- 
to carboxy-peptides. The amino-terminal peptide containing 
DCVs and ELH containing DCVs are also differentially dis- 
tributed in the different neuronal processes emanating from 
the  bag  cells  (Sossin  et  al.,  1990b).  It has,  thus,  been 
hypothesized that the timing and cellular location of the 
tetrabasic  cleavage which liberates  the two intermediates 
from the ELH prohormone is a crucial step in the sorting of 
bioactive peptides derived from the ELH prohormone. 
In pursuit of the molecular mechanisms involved in the 
differential packaging of the ELH prohormone products, we 
investigated the processing of the ELH prohormone in the 
mouse anterior pituitary cell line, AtT-20 (Jung and Scheller, 
1991). AtT-20 cells are able to process exogenous prohor- 
mones, such as proinsulin, and sort processed products into 
the regulated secretory pathway (e.g., Moore et al.,  1983). 
Additionally, it has been demonstrated that a regulated secre- 
tory protein can redirect a constitutive secretory protein to 
the DCVs (Moore and Kelly, 1986). In many of these cases, 
the prohormone contains only one bioactive peptide. The or- 
ganization of  the ELH prohormone is more complex by com- 
parison; its maturation involves at least nine cleavages.  Our 
previous studies showed that in transfected AtT-20 ceils, the 
ELH prohormone is initially cleaved at the unique tetrabasic 
site  and  that  the  carboxy-terminal  intermediate  is  then 
cleaved to yield mature ELH, which is stored into DCVs. 
The amino-terminal intermediate and its products are not de- 
tected in DCVs, and thus it appears that the two intermediates 
are differentially sorted. Hence, processing and sorting of 
the carboxy-terminal intermediate of the ELH prohormone 
in AtT-20 cells is similar to that in the bag cells (Jung and 
Scheller,  1991). 
Our next goal was to examine how the specificity and rim- 
ing of processing governs sorting of peptides derived from 
the ELH prohormone. To this end, we altered the processing 
sequence by mutating the unique tetrabasic site. We show in 
this report that the ELH prohormone lacking the tetrabasic 
site is cleaved at alternative sites. While processing is slower 
than that of wild-type prohormone, mature ELH is still pro- 
duced and stored in DCVs. However, after deleting the tetra- 
basic site and an additional cleavage site, the amino-terminal 
products are now sorted to DCVs. Thus, altering the process- 
ing sites and location of processing in the secretory pathway 
changes the sorting of the ELH prohormone peptide prod- 
ucts. We conclude that the organization of proteolytic pro- 
cessing sites is a major determinant in the sorting of peptides 
derived from this prohormone, and that the propensity of 
mature ELH to be stored in DCVs is dominant over the tar- 
geting of the amino-terminal intermediate products to the 
constitutive pathway in AtT-20 cells. 
Materials and Methods 
Antibodies 
ELH antiserum was raised previously by Fisher et al. Two peptides were 
synthesized with a cysteine at the carboxy terminus: peptide F3A-C to the 
first 32  amino acids of the amino terminal intermediate (A-S-V-H-G-K- 
N-F-A-T-N-R-A-V-J-S-S-S-P-F-V-V-L-S-PoD-D-N-V-V-S-N-S-C) and peptide 
F3B-C to the first 20 amino acids of fragment F3B (D-Q-D-E-G-N-F-R-R- 
F-P-T-N-A-V-S-M-S-A-D-C).  The peptides were purified by HPLC  on a 
preparative C-18 column (~ydac, Hesperia, CA), eluted with acetonitrile, 
0.1% TFA. The pepfides then were coupled to keyhole limpet hemocyanin 
(KLH) via cysteine groups using the heterohifunctional crosslinker sulfo 
SMCC (Pierce, Rockford, IL) and separated from uncoupled peptide by gel 
permeation on Sephadex G-50 (Pharmacia Fine Chemicals, Piscataway, NJ) 
equilibrated in PBS. The two peptides were also coupled to BSA via amino 
groups of the peptide using sulfo SMCC. 
Female New Zealand white rabbits were initially injected with 200 #g 
of peptide-KLH  conjugate  in  Freund's  complete adjuvant  (Sigma,  St. 
Louis, MO) with PBS in a final volume of 1 ml. The rabbits were then 
boosted four times at 20-d intervals with 200 #g of peptide-KLH conjugate 
in Freund's incomplete adjuvant (Sigma). The final bleeds were taken 9 d 
after the last boost and serum was obtained by centrifugation of the blood 
at 4°C and stored at  -70°C. 
F3A-C and F3B-C antisera were affinity purified by passing 3 mls of se- 
rum diluted in 12 mls of PBS over a 1.5 ml column in which I nag of peptide 
was conjugated via cysteine to Afligel 10 (Pierce). The diluted antisera was 
passed over the column three times or was incubated with the resin for 
3 h at 4"C with rotation. 
The column was washed as follows: 10 mls of PBS, 10 mls of PBS with 
0.3 M NaC1,  10 mis of PBS, 10 mis of PBS with 1.0 M urea, and 10 mis 
of PBS. The antibody was eluted with 0.1 M glycine at pH 2.5 and 1-ml 
fractions were neutralized with 1.5 M Tris, pH 8.8 to 7.0-7.5. Fractions were 
stored with 1 mM sodium azide and  10%  glycerol at  -20°C.  Approxi- 
mately 0.5 to 1.0 rag of antibody was recovered. 
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ART-20 cells were cultured in DME H-21 supplemented with 10% FCS and 
penicillin-streptomycin  at 100 U/ml, 12.5% CO2, and 37°C. Transfections 
were performed by calcium phosphate precipitation (Cben and Okayama, 
1988). In a typical transfection, a 10-cm plate at 70% confiuency was trans- 
fected with 50/~g of the PRc/CMV plasmid (Invitrogen, San Diego, CA) 
containing the ELH eDNA. Stable transfectants were selected with 0.25 
mg/ml  (active  drug)  of Geneticin  (GIBCO/BRL,  Galthersburg,  MD). 
G418-resistant clones were selected and those expressing ELH were further 
selected by light level immunocytochemistry using rabbit antisera against 
mature ELH. Several clones from each construct with different levels of ex- 
pression were obtained and used for these studies. 
In Vitro Mutagenesis and Plasmid Construction 
Mutations  of the  ELH  prohormone were produced  by  oligonucleotide 
directed mutagenesis (Kunkel, 1985).  A eDNA encoding the ELH prohor- 
mone (clone U; Mahon et al., 1985) was inserted into the EcoRI site of the 
KS- plasmid (Stratagene, La Joila, CA). The deletion of Arg-Arg was pro- 
duced with the following oligo:  5ACGGAAACJCCACTCATCTGTCCTA 
ACGCCT3'. Deletion of the tetrabasic site was made with 5ACCJGAAAGC 
CACTCAAAACGGTCTGTCCTA3'.  The tetra-tri deletion was performed 
by using the tetra mutant and looping out the tribasic site with 5'CGCTTC 
TACTCCTTAGCA~'I'GGA.  Eight to ten colonies were selected 
and single-stranded DNA was sequenced (dideoxy; Sanger et al., 1977) to 
select for the mutated ELH prohormones. The insert was excised at the 
flanking EcoRI sites and then blunt end ligated into the HindIII site of the 
PRc/CMV vector. 
Light Level lmmunocytochemistry 
Cells were plated on 8-well Permanox slides (Nunc, Roskilde, Denmark) 
and grown to 60% confluency. Cells were fixed in 3.5% paraformaldehyde 
in PBS for 30 rain at room temperature. After fixation, cells were washed 
three times for 15 rain in 0.1 M glycine-PBS, and then permeabilized for 
5 min in 0.4% Saponin, 5% normal goat serum, 1% BSA, in PBS. Affinity- 
purified antisera was added at 2-5 ~tg/ml in the permeabilization buffer and 
incubated at room temperature for 45 rain.  After three washes, the cells 
were incubated for  1 h  with goat anti-rabbit conjugated to fluorescein 
(Chemicon Intl. Inc., Tennecula, CA), diluted 1:100 in permeabilization 
buffer,  and  washed three times.  The cells were overlaid with Citifluor 
(Citifluor LTD,  London) to inhibit quenching. 
ImmunogoM Labeling of Transfectants 
Transfected ART-20 cells were grown to '~80% conftuency in six-well cul- 
ture plates. Media was aspirated and cells fixed in either 4% paraformalde- 
hyde and 0.2% glutaraldehyde in 0.12 M phosphate buffer, pH 7.2, or in 
0.5% glutaraldehyde in 0.12 M phosphate buffer, pH 7.2, for 30 rain on ice. 
After washing with buffer, cells were scraped from the wells and pelleted 
at  1,000  g  for  10 rain.  The pellets were dehydrated to 50%  ethanol at 
-20°C,  stained for 2 h with 2% uranyl acetate in 50% ethanol at 20°C, 
dehydrated to 100% ethanol, and infiltrated with Lowicryl K4M overnight. 
Pellets were embedded the following day at -35°C in flat molds using UV 
polymerization of the resin for 48 h. 
Sections (65 run) of the different transfectants were collected on nickel 
grids, incubated 10 min on 1% sodium borohydride, 10 rain in a solution 
of 5% normal goat serum, and 1.5% BSA in PBS, and overnight in the pri- 
mary antisera, either affinity-purified  anti-ELH or affinity-purified  anti-F3A 
peptide. The antibodies were used at final concentrations of approximately 
10 ng//tl in PBS containing 0.5% normal goat serum and 0.15% BSA. Grids 
were washed three times in PBS over a 90 rain period and transferred to 
secondary label, either protein A conjugated 10-urn gold colloid (Amer- 
sham Corp., Arlington Heights, IL), or goat anti-rabbit conjugated 10 um 
gold colloid (Biocell).  After a  4-h incubation, grids were washed three 
times in PBS over 60 rain, three times in water over 30 rain, and contrasted 
with uranyl acetate and lead citrate. 
Micrographs were taken at 54,800 magnification on a Philips 410 TEM 
(Philips Electronic Instruments, Inc., Mahwah, NJ). 
Quantitation of  lmmunogold Labeling 
Each labeling experiment was repeated at least three times for each trans- 
fected prohormone construct.  DCVs were defined as relatively circular 
electron-dense profiles, and their areas were measured using a  series of 
overlays of defined size. For each quantitation, the number of DCVs corre- 
sponding to each size overlay was counted and the total area calculated. The 
total number of gold particles in all DCV areas was divided by this total 
area to yield the absolute density of immunogold labeling shown in Table 
I. Golgi areas were defined as stacks or series of electron-lucent cisternae 
lacking ribosomes, and their areas measured in the same manner as for 
DCVs. Background, or nonspecific labeling, was measured in the cytoplasm 
by counting all gold particles not associated with defined Golgi or DCV 
areas. The absolute densities of immunogold labeling for at least three sepa- 
rate experiments were averaged to yield the values shown in Table I, and 
the standard deviation calculated. 
Pulse Chase Experiments 
10-cm dishes of  each transfectant at 80% confiuency were washed two times 
with 3 ml of methionine-cysteine deficient media and then prestarved in 
2.5-mls deficient media with 2% FCS for 1 h. 0.25 mCi of Expres (New 
England Nuclear, Boston, MA; >70% [35S]methionine,  [35S]cysteine) was 
added and the cells were incubated for 10 win. Cells were then washed one 
time with 2 mls of regular media supplemented with 1 mM methionine and 
cysteine, fed with 2.5 mls of these media, and incubated for the indicated 
times. At the appropriate time point, these media were collected, and 1 mM 
PMSF was added while cells were harvested with 1 ml of lysis buffer (50 
mM Hepes, pH 7.25,  1% NP-40, 0.15 M  NaCI, 2 mM leupeptin,  1 mM 
PMSE 2 mM EDTA). 
lmmunoprecipitations 
Cells were incubated in lysis buffer at 4°C for 1 h and then spun for 15 rain 
in a microfuge (Beckman Instruments) at 4°C. The supernatant was diluted 
with one volume of lysis buffer without NP-40, and 50/tl Sepharose CL-6B 
slurry (Pharmacia Fine Chemicals) (I:D was added for preclearing. The cell 
extracts and media were incubated for 1 h with rotation at 4°C, and then 
the Sepharose was pelleted by a l-rain spin at 4°C in the microfuge. Super- 
natants were transferred to new tubes and a 10-/~1  aliquot of  each cell extract 
was saved for protein determination. BSA was added and samples were in- 
cubated with rotation overnight at 4°C. 17/~ls of  protein A Sepharose (Phar- 
macia Fine Chemicals) slurry (1:1) was added to each sample and incubated 
with rotation for 2 h at 4°C. Protein A Sepbarose was pelleted by a  10-s 
spin and the supernatant discarded. The protein A Sepbarose pellets were 
washed once in 50 mM Hepes, pH 7.25, 0.5% NP-40, 0.15 M NaC1, 2 mM 
EDTA, 2 mg/nfi BSA, and then two times in 20 mM Hepes, pH 7.25, 0.3 M 
NaC1,  1 mM EDTA, BSA 2 mg/ml, and once in 20 mM Hepes, pH 7.25. 
The pellets were then suspended in 25/~1 of gel loading buffer and heated 
at 100°C for 10 min. After centrifugation, the supernatant was loaded onto 
a 20 % SDS-polyacrylamide gel which contained a separating gel buffer sys- 
tem of pH 9.3 (Hoeffer Scientfic Instruments, San Francisco, CA). Gels 
were run at 15 mAmps, fixed in 25% ethanol, 10% acetic acid, incubated 
for 30  min  in Amplify (Amersham Corp.),  dried and then exposed to 
X-omat film (Eastman Kodak, Rochester, NY) at  -70°C. 
Quantitation of  Storage and Release 
The four different transfectants were grown in duplicate 10-cm plates to 
'~80% confluency. Both sets were treated for pulse chase experiments as 
described above, and cells were pulsed with 0.25 mCi of [3SS]methionine, 
[35S]cysteine for 10 rain. The plates were placed on ice and harvested in 
1 rid of lysis buffer.  The other set was washed, and 3 mls of chase media 
were added for 120 rain. The samples at each time point were divided into 
two aliquots. One aliquot was immunoprecipitated with affinity purified 
ELH  antisera  and  the  other  with  F3A-C  antisera.  The  samples  were 
processed as described above. Quantitation was performed by scanning the 
autoradiograms with a laser densitometer (Molecular Dynamics, Inc., Sun- 
nyvale, CA) and then by using the volume method for quantitation of the 
bands. 
Radiosequencing 
Cells in a 10-cm plate at 80% confluency were pulsed with 0.5 mCi of Ex- 
pres  (New  England  Nuclear)  for  2  h  and  then  chased  for  2  h.  Im- 
munoprecipitations of either the cell extract or media were carried out as 
described. After the 20 mM Hepes wash, the protein A Sepharose pellet 
was resuspended in 30 pls of I N HCI for 2 min, spun, and the supernatant 
collected. This was repeated one time, and the supernatants were then 
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sequencer by Applied Biosystems (Foster City, CA); the fractions from each 
round of Edman degradation were collected and counted with scintillation 
fluid. 
Results 
Antibody Specificity 
In our earlier studies,  we could not detect the presence of 
amino-terminal intermediate products with the antibodies 
available at that time. However, these antibodies are able to 
detect amino-terminal products in bag cell sections embed- 
ded in Lowicryl K4M (Fisher et al., 1988). As the previous 
antibodies were generated against peptides of 10 amino acids 
or less, two new antibodies were generated. Antibody F3A-C 
was generated against the first 30 amino acids of the F3A in- 
termediate (Fig.  1); antibody F3B-C is against the first 20 
amino acids  of the F3B intermediate (Fig.  1).  To test the 
efficacy of the F3A-C and F3B-C antibodies for light level 
immunocytochemistry, bag cell sections embedded in l.,owi- 
cryl K4M (Kreiner et al.,  1986)  were incubated with anti 
F3A-C or F3B-C, and visualized with goat anti-rabbit IgG 
conjugated to fluorescein. Punctate staining was seen in the 
bag cell body and was blocked with the corresponding pep- 
tides. These antibodies immunoprecipitate prohormone and 
amino-terminal intermediate from bag cells, but immuno- 
precipitation of the F3A or F3B intermediate products was 
variable.  The ELH antibody was previously characterized 
and shown to specifically react with mature ELH, as well as 
prohormone (Fisher et al.,  1988). 
Construction of the Mutant ELH Prohormones 
Earlier experiments suggested that cleavage at the unique 
tetrabasic site (Arg-Arg-Lys-Arg) was crucial to the differen- 
tial sorting of  the amino- and carboxy-terminal intermediates 
(Sossin et al.,  1990a). Therefore, we chose to mutate this 
tetrabasic site in two ways. First, we deleted the Arg-Arg pair 
leaving a Lys-Arg site (Fig. 1), a common proteolytic recog- 
nition site.  Analysis of the processing of this construct is a 
way to ascertain the importance of a tetrabasic site cleavage 
versus a dibasic cleavage site.  Second, the entire tetrabasic 
site was deleted, resulting in a precursor that has no cleavage 
site at this position. Third, based on results with the tetra- 
basic  site  deleted  clone  (see  below),  we  constructed  a 
tetra-tribasic  deleted prohormone in which the tetrabasic 
site and an amino-terminal tribasic site were both deleted 
(Fig.  1). 
Selection of the ELH Mutant Prohormones Clones 
The wild type and mutated ELH prohormone cDNAs were 
inserted into the PRc/CMV vector and transfected into AtT- 
20 cells via the calcium phosphate method. With this expres- 
sion  vector,  80%  of the  G418-resistant  clones  were  im- 
munoreactive with the ELH antisera at the light level. Three 
clones of each construct which expressed various levels of 
the transfected ELH were selected. Quantitative Northern 
analyses (Chomczynski and Sacchi,  1986) were performed 
and a set of clones was chosen which express the transfected 
cDNA at levels within threefold of each other. This set was 
analyzed further, and was designated as follows: EC3 (WT), 
ELH wild type prohormone; D'36 (DBA), prohormone in 
Figure 1.  The egg laying prohormone  structure  and processing 
scheme. The ELH prohormone consists of a signal sequence and 
several bioactive peptides, the c~, b, and 3' bag cell peptides, and 
ELH. The internal cleavage sites are indicated by the vertical solid 
black bars, and the basic residue cleavage  sequence is shown above. 
After the signal sequence is removed, the first cleavage occurs at 
a unique tetrabasic site. This partitions the ELH prohormone into 
the amino- and carboxy-terminal intermediates, labeled F2 and 13, 
respectively. In the bag cell neurons, these two intermediates are 
sorted at the TGN to distinct classes of vesicles. The F2 intermedi- 
ate is further processed into the bag cell peptides and the 13 inter- 
mediate into ELH. The tetrabasic and tribasic processing sites that 
are mutated in this study are shaded. 
which the Arg-Arg of the tetrabasic site is deleted leaving a 
dibasic Lys-Arg; TD6 (TBA), prohormone with the tetra- 
basic site deleted; and T3 (TTA), prohormone with the tetra- 
basic and tribasic sites deleted (Fig.  1). 
Expression and Localization of the ELH Prohormone 
in AtT-20 cells 
ART-20 cells have an elongated morphology and concentrate 
secretory  granules  containing  peptides  derived  from the 
proopiomelanocortin precursor at the tips of the processes. 
In the transfected cells, ELH immunoreactivity is seen at the 
tips of the processes, as well as in the perinuclear region of 
each of the clones (Fig. 2). This staining is blocked with the 
ELH  peptide;  untransfected  ART-20  cells  are  not  im- 
munoreactive with  the  ELH antibody.  The  four different 
clones were also incubated with the F3A-C or F3B-C anti- 
bodies which react with the amino-terminal region of the 
ELH precursor. In contrast to the results observed with the 
ELH antibody, staining of amino-terminal peptides is absent 
throughout the cells in all of the clones except for the tetra- 
tribasic-A transformants.  In the tetra-tribasic-A clone, im- 
munoreactivity is observed predominantly in the tips of the 
processes (Fig. 2 D). Variable levels of immunoreactivity are 
also  observed  in  ~o25%  of the  tips  of processes  in  the 
dibasic-A clone.  The amino-terminal antibody staining  is 
blocked with the corresponding peptide and untransfected 
ART-20 cells do not stain.  Thus, ELH immtmoreactivity is 
readily expressed in the wild type and all the mutant clones, 
but amino-terminal products are consistently detected only 
in the tetra-tribasic-A-transfected cells. 
Localization to the tips of processes is indicative of pro- 
teins that are stored in DCVs, but this is not always the case, 
since the immunoglobulin light chain also localizes to the 
The Journal  of Cell Biology,  Volume 121, 1993  14 Figure 2.  Localization of the 
ELH  precursor  proteins  in 
transfected AtT-20 cells. Cells 
were  stained  with  affinity 
purified  ELH  antiserum  and 
F3A-C  antiserum  and  then 
with goat anti-rabbit antibody 
conjugated to fluorescein. (A) 
The  wild  type  clone  (WT) 
stained with anti-ELH shows 
staining primarily at the tips 
of the processes and the poles 
of the cells. The dibasic-A and 
tetrabasic-A also show similar 
staining.  (B)  The  wild  type 
clone stained with anti-F3A-C 
shows no staining throughout 
the  cell.  The  dibasic-A  and 
tetrabasic-A clones also show 
no staining with this antibody. 
(C) The tetra-tribasic-A clone 
stained  with  anti-ELH  also 
shows  immunoreactivity pri- 
marily  at  the  tips  of  the 
processes  and  poles  of  the 
cell.  (D) The tetra-tribasic-A 
clone stained with anti-F3A-C 
shows  prominent  staining  at 
the tips of the processes and 
poles of the cells. Bar, 33/~m. 
tips. Thus, we determined the subcellular localization of the 
ELH and amino-terminal immunoreactivity by immunoelec- 
tron microscopy. ELH immunoreactivity was found primar- 
ily in dense core vesicles of all four different clones, as op- 
posed  to  the  other  compartments  within  the  cell  (Fig.  3, 
Table  I).  This,  along  with  biochemical  data  (see  below), 
confirms that mature ELH is sorted into DCVs of the regu- 
lated pathway. Furthermore,  ACTH and ELH were found to 
colocalize in the DCVs of AtT-20 cells transfected with the 
wild type ELH cDNA (Jung and Scheller,  1991).  The trans- 
fected cells were also incubated with the amino-terminal in- 
termediate antibodies, F3A-C and F3B-C, and immunoreac- 
tivity was observed only in the DCVs of the tetra-tribasic-A 
clone (Table I). These data imply that the amino-terminal in- 
termediate has been redirected  to the DCVs in this  mutant 
construct.  The absence of staining with the amino-terminal 
Figure  3.  ELH  precursor 
products  are  localized  in 
dense  core vesicles in  trans- 
fected AtT-20  cells.  Sections 
of each of  the four clones were 
stained  with  affinity purified 
antiserum and then with goat 
anti-rabbit conjugated  10-nm 
gold colloid.  (A) In the wild 
type clone,  ELH  immunore- 
activity  is  seen  primarily  in 
the DCVs. (B) In the wild type 
clone there  is  no  staining  in 
the  DCVs  with  anti-F3A-C. 
(C) ELH immunoreactivity is 
seen in the DCVs of the tetra- 
tribasic-A clone, and (D) im- 
munoreactivity  with  anti- 
F3A-C  is  also  seen  in  the 
DCVs of this mutant. Bar, 150 
am. 
Jung et al. ELH Prohormone Processing in AtT-20 Cells  15 Table L Quantitation of  lmmunogold Labeling of  AtT-20 Transfectants* 
WT/ELH~  DB/ELH  TB/ELH  WT/ELH  WT/F3A-C  WT/F3B-C  TT/ELH  TT/F3A-C  TT/F3B-C 
Dense core vesicles 
Mean density  459  460  324  382  10.9  9.59  451  304  218 
SEM  9  32  25  19.2  0.7  2.5  57.3  34.4  6.9 
Area analyzed  2.8  9.86  6.21  2.83  0.83  1.18  4.91  5.1  6.35 
(square micrometers) 
Golgi apparatus 
Mean density  28.5  32.7  20.7  23.4  29.7  13.9  22.7  11.4  11.1 
SEM  2  5.9  1.6  1.8  2.7  0.63  2.3  1.22  0.23 
Area analyzed  34.2  57.9  54.8  17.7  12.7  17.2  16.5  25  18.6 
(square micrometers) 
Cytoplasm 
Mean density  1.79  1.87  1.52  1.64  3.19  2.08  1.07  1.37  1.01 
SEM  0.49  0.26  0.23  0.16  0.52  0.19  0.13  0.14  0.22 
Area analyzed  177  292  256  119  50.7  75.8  173  209  205 
(square micrometers) 
* Quamitation was performed as described in the Materials and Methods. The data is presented as the mean density  of gold particles per square microns  of surface 
area for specific organelle. 
The form  ofELH prohormone  transfected into  AtT-20  cells/antibody  used for staining sections. Wild type  ELH (W'/);  dibasic-deleted  prohormone  (DB); tetrabasic- 
deleted prohormone (TB); tetra-tribasic-deleted prohormone  (T/). 
antibodies  in  the  wild  type,  dibasic-A,  and  tetrabasic-A 
clone, indicates that there is no, or minimal,  sorting of the 
amino-terminal products to the DCVs. 
As further biochemical confirmation that ELH was stored 
in DCVs, the transfected cells were treated  with a  secreta- 
gogue. Each clone was pulsed for 2  h, chased for 3 h, and 
then treated for 2 h  with 5 mM 8-Bromo-cAMP. In the ab- 
sence of stimulation with secretagogue, ELH is not observed 
in the media (see below). After this treatment,  mature ELH 
was absent or reduced from the ceil extract and present in 
the media of all the clones. A  minor 7-kD ELH-containing 
band was also isolated from the media of the tetra-tribasic-A 
clone (Fig. 4). This band is most likely the result of alterna- 
tive cleavage at the arginine amino-terminal to the ct bag cell 
peptide and the Lys-Arg pair carboxy-terminal to ELH (Fig. 
1). It is not the same as I3, since the tetrabasic and tribasic 
sites have been deleted in this mutant.  Thus, the wild type 
Figure 4. Mature ELH is stored in the regulated  secretory pathway. 
Ceils were pulsed for 2 h, chased for 3 h, and then stimulated with 
5 mM 8-Br-cAMP for 2 h. After this stimulation,  mature ELH was 
immunoprecipitated  from the media (MD)  of the wild type (WT), 
dibasic-A  (DBA),  tetrabasic-A  (TBA),  and  the  tetra-tribasic-A 
(/TA) clones; a minor 7-kD ELH- containing product was also iso- 
lated from the tetra-tribasic-A clone. Mature ELH is not constitu- 
tively released  into the media (see Fig. 5 A). The cell extracts  of 
the  wild  type,  tetrabasic-A,  and tetra-tribasic-A  clones,  show  a 
lower level of ELH compared to the media. 
and all the mutant constructs of the ELH prohormone are 
processed to yield mature ELH peptide, which is sorted into 
the regulated  secretory pathway.  However,  as indicated  by 
immunofluorescence and immunoelectronmicroscopy, amino- 
terminal products derived only from the tetra-tribasic-A con- 
struct are stored in the DCVs. 
Pathway of Processing 
To identify the stored and secreted  products,  the order of 
processing, and the site of sorting of the ELH prohormone 
products,  pulse-chase  experiments  were performed on the 
ELH-transfected AtT-20 cells. In the first set of experiments, 
ELH antiserum was used to follow the processing of the pro- 
hormone. After a 10-rain pulse, prohormone is the predomi- 
nant product in the wild type clone (Fig. 5 A). After a  120- 
min chase period, ELH is stored in the cell and I3 is secreted 
into the media. In the dibasic-A clone, the prohormone and 
both a 9-kD intermediate and I3 are present at time 0. At 120 
min, the dibasic-A clone is very similar to wild type, in that 
mature ELH is present in the cells and the 13 intermediate 
is secreted into the media. Prohormone is also initially pres- 
ent at time 0  in the tetrabasic-A  cells  and mature  ELH is 
stored in the ceils; however, a 9-kD ELH-containing inter- 
mediate is secreted into the media,  instead of I3.  We also 
variably observe both a  16- and the 10-kD intermediate (Fig. 
5 A) secreted into the media from the tetrabasic-A clone. To 
identify the cleavage which produced these two new inter- 
mediates,  cells  were  pulsed  with  [35S]methionine  for  2  h 
and then chased for 2 h; the media was then immunoprecipi- 
tated and the products were subjected to radiosequencing. 
Counts were detected in cycle seven, indicating that the 9-kD 
protein is produced by cleavage at the tribasic site and based 
on its  size,  the  16-kD protein  is  likely to be produced by 
cleavage after the 3' bag cell peptide (Fig.  1). The processing 
of the ELH prohormone is also different in the tetra-tribasic- 
A clone. At time 0, prohormone is isolated, as with the other 
clones, but at 120 min, a minor 7-kD ELH-containing pro- 
tein and mature ELH are stored in the cells. In further con- 
trast, the prohormone itself is constitutively secreted into the 
media of the tetra-tribasic-A clone (Fig.  5 A). 
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ing of the wild type and mu- 
tant  ELH prohormones.  (A) 
Immunoprecipitations  with 
anti-ELH.  After  the  10-min 
pulse  (time  0)  prohormone 
(L/) and the carboxy-terminal 
intermediate  (13) are  immu- 
noprecipitated  from the wild 
type cell extract (CE). After a 
120-min chase period, mature 
ELH is stored in the cells and 
13 is secreted  into the media 
(MD). In the dibasic-A clone, 
prohormone,  a  9-kD  ELH- 
containing protein, and I3 are 
immunoprecipitated at time 0. 
After 120 min, mature ELH is 
stored  in the cells,  and I3 is 
secreted into the media.  Pro- 
hormone  is isolated from the 
tetrabasic-A  clone  at time 0, 
and  after  120  rain,  mature 
ELH is present in the cell ex- 
tract. In the media at 120 min, 
a 9-kD ELH-containing pro- 
tein  is secreted  and variably, 
both  a  16- and  10-kD ELH 
containing  proteins  (*)  are 
secreted  into the  media  (this 
sample was run in a urea gel) (Newcomb et al.,  1987). For the tetra-tribasic-A  clone, prohormone is present at time 0. After 120 min, 
the products in the cell extract are mature ELH and a 7-kD ELH-containing protein. At this same time, prohonnone is the primary product 
secreted into the media.  (B) Immunoprecipitations  with anti-F3A-C. At time 0, all the clones contained the prohormone,  and at 120 rain 
the amino-terminal  intermediate  (F2) is secreted from the dibasic-A clone. No apparent products are found from the cell extracts after 
120 rain of chase. F2 and a 16-kD product are secreted into the media from the wild type and dibasic-A clones. Only the 16-kD product 
is secreted  from the tetrabasic-A  clone, and only prohormone is secreted from the tetra-tribasic-A  clone. 
In a parallel set of experiments, the F3A-C antibody was 
used to follow the production of the amino-terminal products 
from the  prohormone  (Fig.  5  B).  Again,  after a  10-min 
pulse, prohormone is recovered from the cell extract of all 
the clones. After a 2 h chase, no amino-terminal products are 
immunoprecipitated from the cell extract.  However, in the 
media of the  wild  type and  dibasic-A  clones,  the  amino- 
terminal intermediate (F2) is recovered along with a  16-kD 
protein which is produced by cleavage of F2 at the tribasic 
site (Fig.  1). These assignments were based on the fact that 
the  F3A-C  antibody is directed  against the  first 32  amino 
acids of F2. The 16-kD intermediate is the primary product 
recovered in the media from the tetrabasic-A clone and the 
prohormone  was  recovered  from  the  media  of the  tetra- 
tribasic-A clone. 
It is notable that no amino-terminal products are immuno- 
precipitated using the F3A-C and F3B-C antibodies from the 
tetra-tribasic-A  clone,  despite  prominent  staining  in  the 
DCVs by immunoelectron microscopy. Western blot analysis 
was also performed on cell extracts of the wild type, dibasic- 
A,  tetrabasic-A,  and  tetra-tribasic-A  clones.  However,  no 
amino-terminal products were detected. We reason that one 
of the following explains the absence of an immunoprecipi- 
tated product:  (a) these antibodies can immunoprecipitate 
the prohormone and intermediate but are incapable of im- 
munoprecipitating the final product; or (b) that F3A or F3B 
are cleaved further and the labeled methionine is not part of 
the immunoprecipitated product. 
Quantitation  of the  stored and secreted ELH-containing 
products was determined for all of the clones. As shown in 
Table II, all the clones contain a  similar amount of mature 
ELH in the cells after a 2-h chase.  However, the dibasic-A 
and tetrabasic-A clones constitutively secrete more ELH in- 
termediate(s) than the wild type and tetra-tribasic-A clones. 
It is not clear why there is such a difference. Quantitation of 
the amount of amino-terminal intermediate or prohormone 
that was constitutively secreted from the clones showed that 
the wild type, dibasic-A, and tetrabasic-A clones secrete at 
least  66%,  while  the  tetra-tribasic-A  clone  secretes  only 
37%  of the  initial  level  of prohormones  into  the  media. 
These data imply that sorting of the amino-terminal inter- 
mediate of the prohormone is altered in the tetra-tribasic-A 
clone compared to the other clones, and support the storage 
of amino-terminal products in the DCVs, as shown by the im- 
muno EM data (Table I). 
lime Course and Localization of Processing 
To identify where the first cleavage occurs, a time course ex- 
periment was performed in which the cells were pulsed for 
10 min and chased every 5 rain up to 20 rain. After the 20 
min of chase, the prohormone is almost fully cleaved at the 
unique tetrabasic site in the wild type- and dibasic-A-deleted 
clones. However, ,x,50 % of the prohormone is processed to 
the 9-kD  intermediates  in  the  tetrabasic-A clone,  and the 
prohormone remains almost completely unprocessed in the 
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WT  WT  DB  DB  TB  TB  TT  TT 
CE  MD  CE  MD  CE  MD  CE  MD 
ELH products 
Percent total  51.68  32.52  35.43  66.75  50.10  60.30  71.43  15.47 
SEM  4.05  11.00  5.70  10.62  0.60  1.10  12.90  1.99 
Amino-terminal products* 
Percent total  66.17  -  98.33  -  68  -  37.1  - 
SEM  16.9  -  19.22  -  12.89  -  5.26  - 
* Transfectants were treated as described in the Materials and Methods. Dta is from the quantitation of several experiments as shown in Fig. 5. ELH-containing 
products  were  immunoprecipitated  with anti-ELH  and amino-terminal  products  with anti-F3A-C. The values  are reported  as the percent of  total, which  is the amount 
stored in the cell (CE) or secreted in the media (MD), after a 120-rain  chase period, divided by the total amount isolated at time 0. Wild type prohormone  (W'/); 
dibasic-deleted prohormone (DB); Tetrabasic-deleted prohormone (TB); Tetra-tribasic-deleted prohormone  (T/). 
~: The percent total of amino-terminal products in the cell extract is not reported as none were detected. 
tetra-tribasic-A  clone (Fig.  6).  In the bag cells,  EM auto- 
radiographic experiments demonstrate that the initial tetra- 
basic cleavage occurs in a  late compartment of the Golgi, 
possibly TGN. In the wild type AtT-20 transfected line, the 
prohormone was cleaved only at the tetrabasic site and fur- 
ther cleavages were prevented when the clone was treated 
with the carboxylic ionophore monensin (Jung and Scheller, 
1991).  This  was  also  the  case  in  bag  cells  treated  with 
monensin (Sossin et al.,  1990a).  At 20°C,  proteins do not 
exit  from the  TGN,  and  are  trapped  in  this  compartment 
(Saraste and Kuismanen,  1984).  To study the site of initial 
cleavage,  all  four clones  were  pulsed  for 5  min  and then 
chased for 1 h  at 20°C (Fig. 7). When immunoprecipitated 
with the ELH antibody, the carboxy-terminal intermediate is 
isolated from wild type and dibasic-A clones. The 16.3- and 
9-kD intermediates  and the prohormone are isolated from 
the tetrabasic-A clone, and only the prohormone is detected 
in the tetra-tribasic-A clone. This indicates that in the wild 
type,  dibasic-A,  and tetrabasic-A cells,  the initial  cleavage 
occurs late in the Golgi complex, possibly at the TGN, but 
in  the  tetra-tribasic-A  clone  the  cleavage occurs  after  the 
TGN. 
We also believe the TGN is the site of the initial cleavage 
in  the  wild  type prohormone,  based  on experiments  with 
Brefeldin A. In cells treated with Brefeldin A, there is a mix- 
ing of the ER and cis-,  medial-,  and trans-Golgi  compart- 
ments, but the TGN is not included (Chege and Pfeffer, 1990; 
Reaves and Banting,  1992).  When the wild type clone was 
pulsed and chased in the presence of Brefeldin A, only pro- 
hormone was isolated (Fig. 7). This implies that cleavage at 
the  tetrabasic  site  was  blocked  because  the  prohormone 
could not enter the TGN. In combination with the immuno- 
electronmicroscopy and pulse-chase experiments,  we inter- 
pret these data to mean that in the tetra-tribasic-A clone, the 
entire (unprocessed) prohormone is sorted to DCVs and then 
processed to release  the observed products. 
Discussion 
Processing of the ELH prohormone in the bag cells of the 
marine  mollusc  A.  californica  includes  nine  proteolytic 
cleavages. It is interesting that the processing and sorting ma- 
chinery of the mammalian AtT-20 cells is able to recognize 
the structural features of the ELH prohormone, and process 
it in a similar manner to that of  the bag cells. When wild type 
ELH prohormone is expressed in AtT-20 cells, the tetrabasic 
site is cleaved in a late Golgi compartment, probably TGN; 
the amino-terminal and carboxy-terminal intermediates are 
separated and differentially sorted in a manner similar to the 
bag cells. A portion of the carboxy-terminal intermediate is 
Figure 6.  Initial  processing of the wild type and mutant prohor- 
mones. Clones were pulsed for 5 min and then chased at 5-min in- 
tervals.  After the pulse (time 0), prohormone is present in all the 
clones.  After 20 rain of chase, at least 90% of the prohormone in 
the wild type and dibasic-A clones has been processed to I3 (10-kD 
protein in WT, time 20 lane,  is not ELH specific).  However, at 20 
rain only 50% of the tetrabasic-A  prohormone has been processed, 
and virtually none of the tetra-tribasic-A  prohormone has been 
processed. 
Figure 7. 20°C temperature block. Cells were pulsed for 5 min and 
then chased for 1 h at 20°C. The cell extracts were immunoprecipi- 
tared  with anti-ELH and processed as described in the Materials 
and Methods.  The carboxy-terminal intermediate  (13) is the pre- 
dominant product in the wild type and dibasic-A clones.  In the 
tetrabasic-A  clone, prohormone, 16.3- and 9-kD ELH-containing 
proteins  are isolated:  prohormone is the primary product from the 
tetra-tribasic-A  clone.  In wild  type cells  treated  with  BFA  (10 
#g/ml) for 1 h and then pulsed for 1 h in the presence of BFA, pro- 
hormone is the primary product. 
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most of the amino-terminal intermediate is constitutively 
secreted into the media. In the bag cells, the amino- and 
carboxy-terminal intermediates are also sorted differentially 
but into distinct classes of regulated DCVs, suggesting that 
these neurons have an additional specialization within the 
regulated secretory pathway. Furthermore, in the bag cells, 
a  portion of the amino-terminal intermediate is probably 
degraded intracellularly perhaps by lysosomes. Transfecting 
mutant forms of the ELH prohormone into AtT-20 cells pro- 
vides opportunities to examine the biological relevance of 
the organization of ELH prohormone processing sites,  to 
study how structural features of this prohormone mediate 
sorting,  and to eventually identify the molecular mecha- 
nisms governing the differential sorting of the ELH prohor- 
mone products. 
The primary goal of this study was to understand how the 
proteolytic processing and the location of processing sites 
regulate sorting of the amino-terminal and carboxy-terminal 
intermediates of the ELH prohormone. Our focus was to mu- 
tate the unique tetrabasic site, which is the first to be cleaved 
and allows separation of the two intermediates. A tetrabasic 
site is not common to prohormones, but is present in some 
proreceptors. More commonly, the dibasic Lys-Arg pair is 
a  recognition site for proteolytic cleavage.  Therefore, we 
constructed the dibasic-A prohormone which contains a Lys- 
Arg pair instead of the tetrabasic site and a tetrabasic-A pro- 
hormone  which  lacks  the  tetrabasic  site.  Curiously, the 
dibasic-A prohormone is cleaved at the now dibasic (for- 
merly tetrabasic) site, and the tetrabasic-A prohormone is 
cleaved primarily at an upstream unique tribasic site. 
The discovery of  furin as a proteolytic enzyme (Van de Ven 
et al.,  1990)  involved in cleaving prohormones, viral pro- 
teins, and receptors, aided our understanding of the impor- 
tance of the order of processing and the structure of the ELH 
prohormone. The first cleavage occurs at the tetrabasic site 
which fits the proposed consensus sequence for furin (Arg- 
X-Arg/Lys-Arg).  Furthermore, ELH prohormone expressed 
in oocytes is cleaved at the unique tetrabasic site (Koruer et 
al.,  1991). The prevailing thought is that furin is localized 
in the Golgi (Breshnahan et al., 1990). Thus, it is likely that 
furin cleaves the ELH prohormone at the tetrabasic site in 
the Golgi or the TGN. However, the dibasic-A prohormone 
is cleaved at the dibasic site, which is not a furin consensus 
sequence site. There are several reasons why this may occur. 
It is possible that another processing enzyme cleaves the 
dibasic-A prohormone with a  similar time course, or that 
there are structural features of the tetrabasic region which fa- 
vor cleavage of even a dibasic pair by furin. Alternatively, 
furin may still recognize this as a site because the basic resi- 
due histidine is present in the P4 position (position P1 is the 
carboxy-terminal residue), as opposed to arginine. In pro- 
rennin, lysine is present in the P4 position of a cleaved furin 
site, even though mutational analysis showed that an arginine 
at P4 is preferred to the lysine (Watanabe et al., 1992).  In- 
terestingly, the tetrabasic-A prohormone is cleaved at other 
potential furin consensus sites, though at a slower rate. This 
suggests that the conformation of the prohormone is  not 
favorable for cleaving these other potential furin sites in the 
wild type prohormone. Thus, we conclude that, along with 
the consensus recognition site, there are secondary and ter- 
tiary structural features that dictate the initial cleavage at the 
tetrabasic site; these structural features are preserved in the 
dibasic-A prohormone. 
In the wild type, dibasic-A, and tetrabasic-A prohormone 
constructs, the amino-terminal intermediates are primarily 
constitutively secreted into the  media.  Consequently, we 
constructed a  new mutant in which the tribasic  site was 
deleted in the tetrabasic deleted prohormone to produce the 
tetra-tribasic-deleted prohormone. In this case, the sorting 
of the products is quite different from the other three con- 
structs. The tetra-tribasic-A prohormone is not cleaved in the 
TGN. ELH is still produced, but there is also a minor 7-kD 
ELH-containing product stored in the DCVs. This indicates 
that deletion of  particular processing sites affects the accessi- 
bility of other sites (i.e., those flanking ELH) and reduces 
the efficiency  of  mature ELH production. These effects could 
be mediated in part by the local environment (e.g., pH and 
ions) of the organdie in which a particular processing en- 
zyme resides. Hence, the conformation of the processing in- 
termediates, and the location and timing of PCE action are 
crucial to the maturation of prohormone products. 
The  most  interesting  result  is  the  presence  of amino- 
terminal immunoreactivity in the DCVs of cells transfected 
with the tetra-tribasic-A prohormone. Thus, by deletion of 
the two favored potential furin sites,  the  amino-terminal 
products are restored to the regulated pathway.  There are 
other cases whereby mutation of  furin sites alters the matura- 
tion of secreted proteins. For example, a mutation in the fu- 
rin cleavage site prevents maturation of blood clotting factor 
IX, resulting in the loss of function (Bentley et al.,  1986). 
However,  maturation  of the  insulin  proreceptor  appears 
unaffected by the lack of processing by furin (Yoshimasa et 
al., 1990).  These data on the processing and sorting of the 
products from mutant ELH prohormones also indicate that 
the sorting information, whether it is a specific signal or an 
effect of aggregation, is not dependent on cleavage of the 
ELH prohormone before sorting. Furthermore, it appears 
that the propensity for sorting of the ELH product into DCVs 
is dominant over the targeting of the amino-terminal prod- 
ucts to the constitutive pathway. This is in agreement with 
other workers (Moore and Kelly, 1986). 
We are now able to rule out scenarios whereby amino- and 
carboxy-terminal peptides are copackaged followed by selec- 
tive degradation in distinct vesicle classes  (Sossin et al., 
1990b) and propose the following model (Fig. 8). The ELH 
prohormone is cleaved possibly by furin when it arrives in 
a late Golgi compartment (TG/TGN). Based on our data, this 
cleavage is very persistent and is probably defined in part by 
secondary or tertiary structural features of the prohormone. 
After this cleavage, the amino- and carboxy-terminal inter- 
mediates travel to a sorting area in the TGN. The amino- 
terminal intermediate is directed to the constitutive pathway; 
a portion of the carboxy-terminal intermediate is sorted to 
the regulated pathway, where it is further processed to pro- 
duce mature ELH which is stored in DCVs. This is the sce- 
nario for the wild type, dibasic-A, and tetrabasic-A ELH 
prohormones. In contrast, when the tetra-tribasic-A prohor- 
mone reaches the site of furin, it is not cleaved and passes 
to the sorting area of the TGN.  The unprocessed prohor- 
mone is then sorted into the regulated secretory pathway 
DCVs where mature ELH and amino-terminal products are 
produced.  Some fraction of both the wild type carboxy- 
terminal intermediate and the tetra-tribasic-A prohormone 
Jung et al. ELH Prohormone Processing in AtT-20 Cells  19 Figure  8.  Processing  and  sorting  model  of the  ELH and  tetra- 
tribasic ELH prohormones in the secretory pathway of  AtT-20 cells. 
This  model  depicts  the pathway of sorting  wild type and tetra- 
tribasic-A ELH prohormones. Both prohormones travel vectorially 
through the Golgi stacks. Once in the TGN, a processing enzyme, 
most likely furin, cleaves the wild type prohormone at the unique 
tetrabasic  site. However, the  tetra-tribasic  prohormone  is  not 
cleaved. At this point, the wild type prohormone  is separated into 
the  amino-  and  carboxy-terminal  intermediates.  The  carboxy- 
terminal intermediate is packaged into DCVs and further processed 
to mature ELH (Korner et al., 1991). The wild type amino-terminal 
intermediate is constitutively secreted and is not further processed. 
The tetra-tribasic-A prohormone is packaged into regulated DCVs 
and further processed to produce mature ELH and amino-terminal 
products. Both the wild type carboxy-terminal intermediate and the 
tetra-tribasic-A  prohormone  are also constitutively  secreted  (not 
depicted) as the sorting of exogenous prohormones to the regulated 
pathway in AtT-20 cells is not absolute (Moore et al.,  1983). 
are constitutively secreted, as the sorting in AtT-20 cells is 
not absolute (Moore et al.,  1983). 
Processing can be viewed as a regulatory step in the final 
sorting of the ELH prohormone products.  In the ELH pro- 
hormone,  the bag cell peptides are encoded in the amino- 
terminal intermediate and ELH in the carboxy-terminal inter- 
mediate. ELH acts as a neuromodulator and a neurohormone, 
while the bag cell peptides act in an auto-regulatory mode. 
When  the  two  intermediates  are  liberated  by  proteolytic 
cleavage in the bag cells, they are physically separated, al- 
lowing the distinct  sorting  signals of each intermediate to 
segregate products to the different classes of DCVs. Thus, the 
localization of furin, or a related enzyme, in the Golgi/TGN 
and a furin consensus site (the unique tetrabasic site) in the 
ELH precursor allow the physiologically active peptides in the 
two parts of the precursor to be differentially packaged and 
localized. Cleavage of the intermediates within the DCVs en- 
sures the copackaging of a specific subset of peptides present 
on the precursor.  In this  way,  different peptides expressed 
from a  single gene can be differentially localized,  in order 
to serve separate functions which together govern a complex 
behavior in the animal. 
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